proliferation, as well as the up regulation of IL-4 and IFN-'y production, are complex manifestations of an evolving T-cell response. The maturation of the T-cell response leads to the production of different patterns of lymphokines, which may be significantly affected, as desired, by dosage, timing, and route of immunization, as well as by the choice of adjuvants.
We have previously observed that specific T-cell tolerance to ovalbumin (OVA) in SJL mice, as measured by the secretion of interleukin 2 (IL-2) by lymph node T cells upon antigen challenge in vitro, could result from the injection of OVA in incomplete Freund's adjuvant (IFA) before immunization with the antigen in complete Freund's adjuvant (CFA). We reported (1) that the amounts of OVA were critical but the site (i.p. or s.c.) of antigen injection was not. Furthermore, the deficient T-cell response to OVA as evidenced by a decrease in IL-2 synthesis, and cell replication upon antigen challenge, was not associated with a decrease in the production of anti-OVA antibodies.
To extend these observations and to further define the type of specific T-cell tolerance achieved by this protocol, we have evaluated the development of T helper cells (Th1/Th2) in the tolerant mice and specifically the secretion, upon antigen challenge in vitro, of IL-4 and interferon -y (IFN-,y) by lymph nodes and spleen T cells of tolerized mice.
The deficiency in IL-2 synthesis was often associated with an increase in IL-4 and a moderate decrease in IFN-,y. Moreover, a comparative analysis of the effect of tolerance induction in lymph node and spleen T cells was very informative. More marked increases in IL-4 and .in IFN--y production were observed by spleen than lymph node T cells upon challenge with OVA in vitro.
The tolerizing injection of OVA in IFA or CFA is apparently highly selective in reducing IL-2 responses and proliferation of lymph node T cells and is associated with a shift to the synthesis of other lymphokines, indicative of the complex regulation of the T-cell response in peripheral lymphoid organs.
MATERIALS AND 
RESULTS
Selective T-Cell Tolerance in Lymph Node Cells After Previous Immunization i.p. or s.c. with OVA in IFA. Selective T-cell tolerance, as evidenced by inhibition of IL-2 synthesis by lymph node T cells of tolerant mice upon antigen challenge in vitro, was observed after either i.p. or s.c. immunization with OVA in IFA or CFA (1) . To further investigate the immune status of these tolerant mice, the production of IFN--y and IL-4 and T-cell proliferation upon antigen challenge in vitro were also assayed.
On day 10 after tolerance induction with OVA in IFA or CFA, mice were immunized at the base of the tail with 100 ,ug of OVA in CFA. On day 20, the mice were sacrificed and cell Abbreviations: OVA, ovalbumin; IL, interleukin; IFN, interferon; Th, T helper. *To whom reprint requests should be addressed.
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suspensions of lymph node and spleen cells were cultured for 24 h to measure IL-2 production, for 72 h to measure IFN-,y synthesis, or for 96 h to assay IL-4 production and T-cell proliferation. Table 1 presents the tolerization and immunization protocols as well as the timing of the various assays for all the experimental groups.
As previously reported (1), earlier immunization with OVA in IFA either i.p. or s.c. causes a significant decrease in proliferative response and IL-2 synthesis by lymph node T cells upon antigen challenge in vitro. These effects are considerably stronger with 1 mg than with 100 ,ug of OVA (Fig. 1) .
The tolerizing effect of previous immunization is much less apparent on the synthesis of IFN--y and barely reduces the synthesis of IL-4. In fact, after tolerization with both 0.1 and 1 mg of OVA s.c., the lymph node cells of tolerized mice show a significant increase in IL-4 synthesis upon antigen challenge compared with the control group.
Failure of Spleen T Cells to Express Specific T-Cell Tolerance After Previous Immunization i.p. or s.c. with OVA in IFA. Contrary to the selective tolerance observed in lymph node T cells following the above immunization protocol, evidenced by markedly reduced IL-2 synthesis upon antigen challenge, the spleen T cells of tolerized animals showed little (at 1 mg of OVA s.c.) or no effect of specific tolerance as evidenced by IL-2 synthesis (Fig. 2 ). There were no marked effects of this treatment on IFN--y production either. However, IL-4 synthesis by spleen T cells was strongly up regulated by the effect of the earlier immunization, which in this case could be clearly interpreted as classical priming, as was the case also for the increased level of specific anti-OVA antibodies on days 20 and 30 after initial immunization (data not shown). OVA/CFA administered i.p. or s.c. on T-cell tolerance induction by using several parameters of T-cell response.
Our previous study (1) and the data presented in this report clearly show that active immune responses are induced by both OVA/IFA and OVA/CFA at day 10 and are followed by a down regulation of IL-2 production by lymph node cells on day 20 after secondary challenge s.c. with 100 pug of OVA in CFA.
Spleen cells in contrast were much less susceptible to suppression of IL-2 synthesis. Moreover, up regulation of IL-4, and to a much lesser extent of IFN-y production by spleen cells, was observed in tolerized mice.
Our data indicate that spleen T cells are more resistant to the down regulation of IL-2 production and more sensitive to the induction of IL-4 responses as compared to lymph node T cells. One milligram of OVA was always more efficient in 
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100 gg OVA * Lymph node and spleen cells. (16, 17) . In contrast, helminth parasite infection induces the production of an elevated level of Th2 cytokines (18, 19 24) in antigen-specific tolerant mice. In contrast, memory T cells have been found to be a potent source of IL-4 (25-27) and IFN--y (25) (26) (27) (28) (29) .
No difference between control mice and tolerant mice was seen in antibody production (data not shown). It has been recognized for a long time that B cells are more resistant than T cells to tolerance induction (30) . Our study therefore suggests that this might be due to the refractoriness of splenic T cells to tolerance induction. Furthermore, the increase of IL-4 production by splenic T cells must be promoting the increase of antibody levels regularly seen in mice primed i.p. and challenged s.c., as compared to mice primed i.p. only (data not shown). Therefore, the increase of IL-4 and IFN-,y that we have seen may most likely reflect the activation of OVAspecific memory T cells.
Our data further illustrate how, in the course of an evolving T-cell immune response, the production of different patterns of lymphokines occurs in distinct peripheral lymphoid organs. These patterns may be significantly affected therapeutically by dosage, timing, and route of immunization as well as by the choice of adjuvant.
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